flydubai inks deal with GE Aerospace for GEnx-1B engines and services to power its first widebody fleet
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation flydubai and GE Aerospace signed an agreement for 60 GEnx-1B engines to power the airline's new fleet of Boeing 787-9s. This agreement underpins flydubai's growth strategy and the continued expansion of its network, enabling the airline to increase capacity on existing routes, and meet demand from a growing passenger base. Established in 2008, flydubai has grown significantly, and currently serves more than 135 destinations across 57 countries; the airline is now addin ...
Why We Could Use a Good, Long Bear Market
WSJ· 2025-11-17 12:00
Stocks have experienced only brief downturns over the past 16 years, creating dangerous complacency. ...
Nvidia CEO Jensen Huang surprised investors with a 'half a trillion' forecast. It'll come up at earnings
CNBC· 2025-11-17 12:00
Nvidia CEO Jensen Huang revealed in October that his company has $500 billion in orders, in 2025 and 2026 combined, for its chips that are at the heart of the AI boom.For a company that has seen its quarterly revenue grow nearly 600% over the past four years, Huang's statement was a sign that Nvidia is confident of another year of strong — but slowing — growth for its next cycle of chips, implying that the AI boom still has room to run."This is how much business is on the books. Half a trillion dollars wort ...
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation In his role on the SAB of NewcelX, Prof. Shefner will provide strategic guidance on the Company's programs in ALS, including the clinical development of AstroRx®, and will support the integration of neuromuscular and neurodegenerative disease expertise into the Company's broader platform of cell therapy and neuroscience innovation. ZURICH and NESS ZIONA, Israel, Nov. 17, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or "the Company"), a clinical-stage bio ...
Hyliion Demonstrates Dynamic Fuel Switching in KARNO™ Power Module, Showcasing the Future of Flexible, Fuel Agnostic Power
Businesswire· 2025-11-17 12:00
AUSTIN, Texas--(BUSINESS WIRE)--Hyliion Holdings Corp. (NYSE American: HYLN) ("Hyliion†), a developer of modular power plant technology, today announced the successful demonstration of dynamic fuel switching in its KARNO Power Module. The system transitioned between natural gas and propane while under load, maintaining continuous power generation without interruption, shutdown, or hardware changes. This demonstration showcases the KARNO system's ability to adapt to new fuel sources in real time. ...
Elemental Royalty Executes Four Option Agreements to Sell Projects in Arizona to Ivanhoe Electric
Newsfile· 2025-11-17 12:00
Elemental Royalty Executes Four Option Agreements to Sell Projects in Arizona to Ivanhoe ElectricNovember 17, 2025 7:00 AM EST | Source: Elemental Royalty CorporationVancouver, British Columbia--(Newsfile Corp. - November 17, 2025) - Elemental Royalty Corporation (TSXV: ELE) (OTCQX: ELEMF) ("Elemental" or "the Company") is pleased to announce that Bronco Creek Exploration Inc. ("BCE"), a wholly owned subsidiary of Elemental has executed four separate option agreements (the "Agreements") with R ...
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement
Globenewswire· 2025-11-17 12:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, and American Molecular Imaging (AMI), one of the leading radiology reading services providers in the U.S., are pleased to announce that they have entered into a strategic business and investment agreement (the “Agreement”), with the ...
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
Prnewswire· 2025-11-17 12:00
Accessibility StatementSkip Navigation Patent covers the use of GLIX1 for treating cancers in which cytidine deaminase (CDA) is not over-expressed (representing over 90% of cancers) Patent further broadens and strengthens GLIX1 patent protection until 2040, with a possible patent-term extension of up to five years TEL AVIV, Israel, Nov. 17, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and ...
Organto Foods Inc. Announces Prepayment of Convertible Notes
Accessnewswire· 2025-11-17 12:00
Optimizes Capital Structure and Financial Flexibility VANCOUVER, BC AND BREDA, NETHERLANDS / ACCESS Newswire / November 17, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQX:OGOFF)(FSE:OGF0) ("Organto" or the "Company"), is pleased to announce that it has completed the previously announced prepayment of all outstanding 10% convertible notes totaling CDN $2,340,850, as part of the Company's ongoing efforts to optimize its capital structure and position for anticipated growth. As previously announced on October 24, ...
Manitoba Mineral Development Fund Grants Canadian Gold Corp. $300,000 to Expand Exploration Program
Newsfile· 2025-11-17 12:00
Manitoba Mineral Development Fund Grants Canadian Gold Corp. $300,000 to Expand Exploration ProgramNovember 17, 2025 7:00 AM EST | Source: Canadian Gold Corp.Flin Flon, Manitoba--(Newsfile Corp. - November 17, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce that it has been approved for an additional $300,000 grant from the Manitoba Mineral Development Fund ("MMDF"). In total, the MMDF has granted Canadian Gold $900,000 since 2023, which has be ...